Cargando…

Effects of midazolam on cardiovascular responses and isoflurane requirement during elective ovariohysterectomy in dogs

BACKGROUND: A prospective, randomized, placebo-controlled, blinded clinical study was conducted to determine whether a single dose of midazolam affects the cardiovascular response to surgical manipulation of the ovaries during elective ovariohysterectomy. Thirty-nine client-owned dogs undergoing ele...

Descripción completa

Detalles Bibliográficos
Autores principales: Kropf, Josephine, Hughes, J.M. Lynne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297997/
https://www.ncbi.nlm.nih.gov/pubmed/30568789
http://dx.doi.org/10.1186/s13620-018-0136-y
_version_ 1783381243861139456
author Kropf, Josephine
Hughes, J.M. Lynne
author_facet Kropf, Josephine
Hughes, J.M. Lynne
author_sort Kropf, Josephine
collection PubMed
description BACKGROUND: A prospective, randomized, placebo-controlled, blinded clinical study was conducted to determine whether a single dose of midazolam affects the cardiovascular response to surgical manipulation of the ovaries during elective ovariohysterectomy. Thirty-nine client-owned dogs undergoing elective ovariohysterectomy were recruited. After scoring cage demeanour, dogs were premedicated with acepromazine (0.03 mg kg(-1)) and pethidine (3 mg kg(-1)) intramuscularly into the quadriceps muscle and 20 min later sedation was scored. Anaesthesia was induced with propofol intravenously (IV) to effect. The study treatment (group M: midazolam (0.25 mg kg(-1)); or group P: placebo (Hartmann’s solution) (0.125 ml kg(-1))) was administered IV before the intra-operative manipulation of the first ovary. Anaesthesia was maintained with isoflurane in oxygen. Morphine (0.3 mg kg(-1) IV) was administered prior to the start of surgery. The vaporizer setting was adjusted according to the depth of anaesthesia. If an end-tidal isoflurane concentration (FE’Iso) above 1.6% was required additional analgesia was provided with fentanyl (2 μg kg(-1)). Dogs received meloxicam (0.2 mg kg(-1) IV) at the end of procedure. Heart rate, mean arterial blood pressure, respiratory rate and end-tidal partial pressure of carbon dioxide as well as FE’Iso were recorded and analysed. RESULTS: A statistical significant difference between groups was detected in FE’Iso, with group M requiring a significantly lower FE’Iso than group P (14.3%) after administration of midazolam. No differences between groups was shown for percentage change in heart rate and mean arterial blood pressure, or end-tidal carbon dioxide and requirement for mechanical ventilation, or rescue analgesia. There was no statistically significant difference in the incidence of complications in group M and P. Group M received significantly more succinylated gelatin solution pre-administration of midazolam than group P, but no differences in fluid administration post-administration of the study treatment (midazolam/placebo) were detected. No statistical significant difference was demonstrated for the use of anticholinergic agents, dobutamine or noradrenaline. CONCLUSION: No significant effect on cardiovascular parameters could be observed with administration of midazolam, but a modest (14.3%) isoflurane-sparing effect was detected.
format Online
Article
Text
id pubmed-6297997
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62979972018-12-19 Effects of midazolam on cardiovascular responses and isoflurane requirement during elective ovariohysterectomy in dogs Kropf, Josephine Hughes, J.M. Lynne Ir Vet J Research BACKGROUND: A prospective, randomized, placebo-controlled, blinded clinical study was conducted to determine whether a single dose of midazolam affects the cardiovascular response to surgical manipulation of the ovaries during elective ovariohysterectomy. Thirty-nine client-owned dogs undergoing elective ovariohysterectomy were recruited. After scoring cage demeanour, dogs were premedicated with acepromazine (0.03 mg kg(-1)) and pethidine (3 mg kg(-1)) intramuscularly into the quadriceps muscle and 20 min later sedation was scored. Anaesthesia was induced with propofol intravenously (IV) to effect. The study treatment (group M: midazolam (0.25 mg kg(-1)); or group P: placebo (Hartmann’s solution) (0.125 ml kg(-1))) was administered IV before the intra-operative manipulation of the first ovary. Anaesthesia was maintained with isoflurane in oxygen. Morphine (0.3 mg kg(-1) IV) was administered prior to the start of surgery. The vaporizer setting was adjusted according to the depth of anaesthesia. If an end-tidal isoflurane concentration (FE’Iso) above 1.6% was required additional analgesia was provided with fentanyl (2 μg kg(-1)). Dogs received meloxicam (0.2 mg kg(-1) IV) at the end of procedure. Heart rate, mean arterial blood pressure, respiratory rate and end-tidal partial pressure of carbon dioxide as well as FE’Iso were recorded and analysed. RESULTS: A statistical significant difference between groups was detected in FE’Iso, with group M requiring a significantly lower FE’Iso than group P (14.3%) after administration of midazolam. No differences between groups was shown for percentage change in heart rate and mean arterial blood pressure, or end-tidal carbon dioxide and requirement for mechanical ventilation, or rescue analgesia. There was no statistically significant difference in the incidence of complications in group M and P. Group M received significantly more succinylated gelatin solution pre-administration of midazolam than group P, but no differences in fluid administration post-administration of the study treatment (midazolam/placebo) were detected. No statistical significant difference was demonstrated for the use of anticholinergic agents, dobutamine or noradrenaline. CONCLUSION: No significant effect on cardiovascular parameters could be observed with administration of midazolam, but a modest (14.3%) isoflurane-sparing effect was detected. BioMed Central 2018-12-17 /pmc/articles/PMC6297997/ /pubmed/30568789 http://dx.doi.org/10.1186/s13620-018-0136-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kropf, Josephine
Hughes, J.M. Lynne
Effects of midazolam on cardiovascular responses and isoflurane requirement during elective ovariohysterectomy in dogs
title Effects of midazolam on cardiovascular responses and isoflurane requirement during elective ovariohysterectomy in dogs
title_full Effects of midazolam on cardiovascular responses and isoflurane requirement during elective ovariohysterectomy in dogs
title_fullStr Effects of midazolam on cardiovascular responses and isoflurane requirement during elective ovariohysterectomy in dogs
title_full_unstemmed Effects of midazolam on cardiovascular responses and isoflurane requirement during elective ovariohysterectomy in dogs
title_short Effects of midazolam on cardiovascular responses and isoflurane requirement during elective ovariohysterectomy in dogs
title_sort effects of midazolam on cardiovascular responses and isoflurane requirement during elective ovariohysterectomy in dogs
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297997/
https://www.ncbi.nlm.nih.gov/pubmed/30568789
http://dx.doi.org/10.1186/s13620-018-0136-y
work_keys_str_mv AT kropfjosephine effectsofmidazolamoncardiovascularresponsesandisofluranerequirementduringelectiveovariohysterectomyindogs
AT hughesjmlynne effectsofmidazolamoncardiovascularresponsesandisofluranerequirementduringelectiveovariohysterectomyindogs